Embryonic diapause is a common reproductive strategy amongst mammals, requiring an intimate cross-talk between the endometrium and the blastocyst. To date, the precise molecular signals responsible are unknown in the mouse or any other mammal. Previous studies in the mink implicate polyamines as major regulators of the control of diapause. In the mouse, inhibiting the ratelimiting enzyme of polyamine synthesis, ornithine decarboxylase (ODC1) during early pregnancy largely prevents implantation, but the fate of the nonimplanted embryos is unknown. To determine whether polyamines control mouse embryonic diapause, we treated pregnant mice with an ODC1 inhibitor from d3.5 to d6.5 postcoitum. At d7.5, 72% of females had no signs of implantation whilst the remaining females exhibited disrupted placental formation and degenerate embryos. In the females with no implantation, we obtained viable blastocysts that had attenuated cell proliferation, indicating a state of diapause. When cultured in vitro, these exhibited trophoblast outgrowth, indicative of reactivation of embryogenesis. In contrast, direct culture of d3.5 blastocysts with an ODC1 inhibitor failed to cause entry into diapause. Examination of the polyamine pathway enzymes and a number of implantation factors indicated inhibition of ODC1 resulted in a uterine phenotype that resembled diapause, with some compensatory increases in crucial genes. Thus, we conclude that an absence or paucity of polyamines induces the uterine quiescence that causes entry of the blastocyst into embryonic diapause.
Introduction
Embryonic diapause is a period of developmental arrest in which the embryo is maintained in a dormant state for an extended period of time. While more than 130 species of mammals undergo embryonic diapause, the molecular mechanisms that control it remain poorly understood [1] . Mammalian embryonic diapause can be induced by either lactational or seasonal factors affecting the relevant endocrine milieu, with consequent effects on the uterus that prevent continued development of the embryo beyond the blastocyst stage. Despite variation amongst species in environmental influences that induce and maintain diapause, the downstream factors at the uterine level appear conserved, even amongst nondiapause species. For example, the Msh homeobox gene (Msx) expression in the mouse uterus is required for quiescence during diapause and its expression is conserved in two other diapause species, the mink, Neovison vison, and tammar wallaby, Macropus eugenii [2] . The potential for diapause may be present in other species, as a recent study has shown that transfer of sheep blastocysts into a diapause mouse uterus resulted in arrest of development, from which, as with species displaying diapause, the embryos could be reactivated and resume normal development [3] .
Mouse embryonic diapause is facultative, in that it is induced by lactation after postpartum mating and by other forms of metabolic stress [4] . Mouse embryos enter diapause at the blastocyst stage at d3.5 and, whilst they undergo hatching from the zona pellucida and are apposed to the uterine lining, they have greatly reduced cell proliferation and are unable to complete the implantation process [5] [6] [7] . Embryonic diapause in the mouse can also be experimentally induced either by ovariectomy on d3.5 and maintained by daily progesterone injections or by injection of an estrogen receptor inhibitor at d2.5 and d3.5, which does not require progesterone [2, 8] . Reactivation of the embryo occurs after a single injection of estradiol and is followed rapidly by implantation 18 h later, similar to the timing of implantation in the absence of diapause, which commences in the evening of d3.5, after the morning estrogen surge [8] [9] [10] . Although the molecular mechanisms of embryonic diapause have been extensively investigated in the mouse, the precise factors required, and their sequence of occurrence in reactivation of the embryo remains unclear [11] .
Our previous global gene expression analysis in the mink revealed reduced expression of a cluster of genes during diapause that regulate the abundance of polyamines in both the embryo and the uterus [12] . Polyamines are a class of positively charged aliphatic amines, found in all living organisms, which play essential roles in regulation of cell growth, differentiation, and cell death (reviewed in [13, 14] ). There are five known polyamines, the three most common of which are putrescine, spermidine, and spermine. Polyamines can bind to and interact with DNA, RNA, chromatin, and protein, and can promote binding between proteins and DNA. They are involved in a multitude of cellular processes including transcription, translation, metabolism, cell cycle control, stress protection, and apoptosis and are essential for numerous reproductive functions (reviewed in [13, 14] ).
Polyamines are formed predominantly from the amino acids ornithine, arginine, proline, and methionine, and their regulation is tightly controlled by multiple enzymes and feedback pathways (reviewed in [15] ). Briefly, ornithine can be formed from either arginine via arginase (ARG) or proline via proline dehydrogenase (PRODH) and ornithine aminotransferase (OAT). The subsequent decarboxylation of ornithine forms putrescine via the enzyme ornithine decarboxylase (ODC1). Once formed, putrescine can bind to decarboxylated S-adenosylmethionine, formed from methionine via Sadenosylmethionine decarboxylase (AMD1), to form spermidine via spermidine synthase (SRM), spermidine can then form spermine via spermine synthase (SMS). This process can also be reversed with the back conversion of spermine to spermidine and spermidine to putrescine via N1-spermidine/spermine acetyltransferase (SAT1) and polyamine oxidase (PAOX). Spermine can also be directly converted back to spermidine via spermine oxidase.
The primary regulation of polyamines occurs through ODC1, the rate-limiting enzyme in polyamine synthesis [14] . Not surprisingly, the expression of ODC1 itself is also tightly controlled at multiple levels [16] . ODC1 has a short half-life, less than 1 h, and its degradation is acutely regulated via ornithine decarboxylase antizyme (OAZ), which binds to ODC1, resulting in both inhibition of ODC1 activity and its degradation [17] . However, the antizyme inhibitor (AZIN), a protein with a similar structure to ODC1 but no activity, can bind to OAZ with a higher affinity, thus preventing ODC1 degradation [17] . Elevated intracellular polyamine concentrations can also control ODC1 by inducing translational repression of the enzyme and increasing the synthesis of OAZ, which can also prevent polyamine uptake and increase their transport out of the cell [18] .
In the mink, polyamines can reactivate the embryo from diapause [19] . Abundance of the transcripts of both uterine and embryonic ODC1, AZIN 1, and SAT1 enzymes significantly increases at reactivation from diapause [12, 19] . Inhibition of ODC1 in vivo with DL-α-difluormethylornithine (DFMO), a potent and selective inhibitor of ODC1 that works through the mechanism of substrate-induced irreversible inhibition [20, 21] , induces reactivated mink embryos to re-enter into diapause [22] . Similarly, DFMO causes an arrest in the proliferation of both mink inner cell mass and trophoblast cell lines in vitro, whilst treatment with putrescine results in proliferation [19, 22] .
In the mouse embryo, ODC1 is present throughout development from the zygote to the blastocyst stage [23] . Although Odc1 germline knockout mouse embryos are able to implant, they fail soon after [23] . Odc1 null blastocysts are unable to maintain proliferation of the inner cell mass in culture and have increased levels of apoptosis, which cannot be mitigated by addition of putrescine [24] . Similarly, in the Amd1 knockout mouse, no embryos are present at the time of expected implantation and Amd1 null blastocysts are unable to survive in culture unless spermidine is present [25] . Treatment of embryos with polyamines in vitro increases the percentage of embryos becoming blastocysts [26] [27] [28] . Thus, polyamines appear essential for preimplantation embryo development.
In the mouse uterus, ODC1 and AMD1 activity and putrescine levels are low during the first 5 days of pregnancy but increase during the implantation period [20] . Consistent with this, inhibiting ODC1 with DFMO in the mouse at various time points during early pregnancy largely prevents implantation [29, 30] . The maximum DFMO treatment effect occurs between d5.5 and d8.5 of pregnancy but effects are also observed when treated at d0.5-d3.5 or d3.5-d5.5 and result in a significant number of nonviable fetuses found at d17.5 [29, 30] . In the embryos that successfully implant, there are significantly increased levels of Amd1 at the implantation sites, suggesting the presence of a compensatory mechanism [31] . However, the fate of the nonimplanted embryos has not been reported and the effect on other elements of the polyamine pathway is unknown.
Polyamines may also regulate embryonic diapause in the mouse. During diapause, there are reduced transcripts for a number of polyamine pathway genes in the uterus, including Odc1, which all then increase at reactivation [31] . Consistent with this, culture of blastocysts with DFMO prevents trophoblast outgrowth and reduces DNA synthesis [27, 32] . Similarly, treatment with DFMO also prevents implantation after estradiol-induced reactivation from diapause by around 75% but again, the fate of the nonimplanted embryos is unknown [31] .
In this study, we hypothesize that polyamines have a function in controlling embryonic diapause and embryo viability in the mouse. The aims of this study were to investigate further the causes of implantation failure in the mouse after ODC1 inhibition and to determine whether polyamines regulate uterine receptivity, independent of implantation. We were also interested in determining whether inhibition of polyamine synthesis can cause the mouse blastocyst to enter into reversible embryonic diapause.
Materials and methods
All procedures involving live animals were approved by the Comité de Déontologie de la Faculté de Médecine Vétérinaire, Université de Montréal, which is accredited by the Canadian Council on Animal Care. Uterine horns from mated females were collected at d3.5, during diapause, and implantation sites were collected at d5.5 and d7.5. Uteri were collected under RNase-free conditions and were either snap-frozen in liquid nitrogen for RNA extraction or fixed overnight in 4% (w/v) paraformaldehyde, washed twice in 1x phosphate buffered saline (PBS), and stored in PBS before paraffin embedding and sectioning. Embryos were flushed from the uterus using prewarmed M2 medium (M7167, Sigma-Aldrich Oakville, Canada) and cultured in defined medium, KSOM, according to the recipe of Lawitts and Biggers [33] Difluormethylornithine treatment Immature females were superovulated by interperitoneal injection of 0.1 ml equine chorionic gonadotrophin (Folligon, Intervet Canada Corp., Merck & Co., Inc., Kenilworth, NJ, USA) followed 44 h later by interperitoneal injection of 0.1 ml human chorionic gonadotrophin (Chorulon, Intervet Canada Corp., Merck & Co., Inc., Kenilworth, NJ, USA) and mated to fertile males (d0.5 = day of vaginal plug). Females were subsequently injected subcutaneously twice daily at 0800 and 1600 h, from d3.5 to d6.5 with 500 mg/kg DFMO dissolved in saline. DFMO was kindly provided by Dr Patrick Woster (Wayne State University, Detroit, MI). Control females were injected with saline following the same schedule as the DFMO injections. Both DFMO and saline-treated females were euthanized 1 day after the end of the treatment regime (d7.5). For all mice, embryos (if present) were flushed from the uterus and uteri were collected and processed as described above. Individual embryos were cultured in KSOM at 37
• C for either proliferation or outgrowth assays.
Cell proliferation assay
Evaluation of cell proliferation in embryos was carried out using the Click-iT EdU imaging kit (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. Briefly, embryos were incubated overnight at 37
• C with 100 μM of EdU diluted in KSOM. After fixation in 3.7% formaldehyde and permeabilization of the samples in 0.5% Triton X-100, EdU was detected by incubation of the samples in the Click-iT reaction cocktail, which included CuSO4 and the Alexa Fluor 595 azide. Nuclei were then counterstained by Hoechst 33 342 before mounting the slides using the mounting medium Permafluor (Thermo Fisher Scientific, Fremont, CA). The signals were visualized by fluorescence microscopy with a PALM MicroBeam
Observer.Z1, AXIO, HXP120 fluorescence (Carl Zeiss Microscopy, Göttingen, Germany).
Embryo culture
Once flushed from the uterus, blastocysts were washed through three drops of KSOM and cultured in the fourth drop. Embryos were cultured at a ratio of one embryo per 2 μl media in groups containing five to ten embryos, under mineral oil in 5% CO 2 and 95% air at 37
• C. Embryos were transferred to new drops on gelatincoated plates once hatched from the zona pellucida, and culture was observed for a total of 5 days to allow for the observation of trophoblast spreading. For the DFMO in vivo experiment, blastocysts were flushed from the DFMO-treated and control uteri and cultured in KSOM. For the DFMO in vitro experiment, blastocysts were flushed from the uterus at d3.5 and cultured in either 10 mM DFMO in KSOM or KSOM alone. In an additional experiment, embryos were flushed from the uterus at d2.5, cultured in KSOM for 1 day to obtain blastocysts, and then transferred to either 10 mM DFMO in KSOM or KSOM alone.
Quantitative RT-PCR in uterine tissue
Total RNA was isolated from uteri with the RNeasy Mini Kit (Qiagen) and DNase-treated using DNase I (RNase-free) (Ambion, Austin, TX, USA) according to the manufacturer's instructions. The quality and quantity of the RNA were verified by optical density reading using a NanoDrop ND-1000 spectrophotometer (BioLab, Thermo Fisher Scientific). An aliquot of 1 μg of total RNA was reversed transcribed in a 20 μl reaction using SuperScript III kit (Invitrogen, Carisbad, CA, USA) with oligo(dT) priming according to the manufacturer's instructions and diluted 1:20 with nuclease-free water. Transcript abundance assay by qPCR was performed using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) with primers at a final concentration of 500 nm and using Bio-Rad provided plastics. Reactions were run in triplicate on a CFX96 Real-Time System with a C1000 Touch Thermal Cycler (Bio-Rad), and results were analyzed using the CFX Manager software. Primers came either from previously published work or were designed based on the available mouse sequence (Table 1) . Primers were initially chosen based on their lack of secondary structures and their specificity by comparing to native sequences using the National Centre for Biotechnology Information (NCBI) BLASTN 2.2.30 program with default parameters optimized for more dissimilar sequences (discontinguous megablast) (https://blast.ncbi.nlm.nih.gov/Blast.cgi). A gradient qPCR was then performed for all primers and an electrophoresis gel run to confirm the presence of a single band, a lack of primer dimers, and to confirm 60
• C as an optimal annealing temperature. To correct the quantification cycle (Cq) values and to calculate the expression levels the amplification efficiency of all primer sets was then determined via a standard curve and established as greater than 1.8 for all genes. This analysis was also used to confirm that the assay was in the linear dynamic range. all genes examined in the uterus, a minimum of five replicates were run per stage for a total of six stages. The negative control reactions contained nuclease-free water instead of template, and plates were discarded if more than one of the negative control triplicates was contaminated. Individual samples of a triplicate were discarded if [46] . bp = base pairs.
they had irregular melting curves or if the coefficient of variation was greater than 0.02. If more than one of the triplicates was irregular, the sample was repeated or discarded.
Four genes (glyceraldehyde 3-phosphate dehydrogenase, Gapdh; hypoxanthine phosphoribosyltransferase 1, Hprt1; ribosomal protein L19, Rpl19; and beta-2-microglobulin, β2m) were initially assessed for use as reference genes to determine the relative expression levels of the transcripts for the genes of interest. The genes Rpl19 and β2m were chosen as the most reliable based on gene stability values and coefficients of variation using the geNORM software incorporated into the CFX Manager software. Analysis was then performed using the geNORM software incorporated into the CFX Manager software (Bio-Rad). It was based on a modification of the "efficiency-corrected comparative quantification method" that incorporates a calibrator sample into the mathematical model and normalizes to multiple reference genes [34] . The subsequent relative quantity values obtained for the replicates of each stage were then averaged and analyzed as described below.
Immunocytofluorescence in uterine tissue
Paraffin cross sections of uterine tissues were used to localize expression of ODC1, AMD1, MSX1, and the proliferation marker antigen identified by monoclonal antibody Ki 67 (MKI67) ( Supplementary Table S1 ). Briefly, after deparaffinization and hydration, antigen retrieval was performed by incubating the sections in citrate buffer pH 6 at 98
• C for 30 min followed by 30 min at room temperature. The sections were then washed and blocked in either 5% (wt/vol) donkey serum (ODC1 and MSX1) or goat serum (AMD1 and MKI67) at room temperature for 1 h. After blocking, the tissues were incubated overnight at 4
• C with primary antibody (ODC1, AMD1, MSX1, or MKI67, Supplementary Table S1) in a humid chamber. After three washes in PBS containing 0.1% Tween 20, sections were incubated for 1 h with either a donkey anti-goat (705-165-003, Jackson laboratory, ODC1 and MSX1) or a goat anti-rabbit (111-165-144, Jackson Laboratory Bar Harbor, ME, USA; AMD1 and MKI67) cy-3 secondary antibody. Nuclei were counterstained with DAPI (D9564, SigmaAldrich) and slides were mounted in Permafluor (Thermo Fisher Scientific). Negative control sections were submitted to the same procedures, except that the first antibody was replaced by blocking solution. 
Statistical analyses
Data are expressed as mean ± SEM. For the qPCR analysis, a boxplot was performed to identify outliers and a Shapiro-Wilks test performed to establish whether the data had a normal distribution. If the distribution of the relative expression values differed significantly from normality, the data were log transformed for analysis and normality confirmed. The qPCR data were analyzed by one-way ANOVA, with the Tukey-Kramer test used for pairwise comparisons of relative gene expression means between stages of pregnancy (only if ANOVA was significant). For blastocyst culture, the percentage of treatment blastocysts versus control blastocysts that were able to spread was analyzed by one-way ANOVA. A probability level of p< 0.05 was chosen as the measure of significance.
Results
Superovulated bred female mice were treated with either DFMO or saline twice daily from d3.5 to d6.5 and examined at d7.5. At d7.5, the majority of the saline-treated controls were pregnant and showed clear signs of implantation ( Figure 1A , Table 2 ). On the other hand, in the DFMO-treated animals, the majority showed no signs of implantation. The remaining animals displayed incomplete or degenerate implantation with irregularly sized and spaced implantation sites ( Figure 1A , Table 2 ). When the nonimplanted uteri from DFMO-treated mice were flushed, half contained blastocysts, many of which were hatched and had few replicating cells, restricted to the inner cell mass, similar to a diapause blastocyst ( Figure 1B , Table 2 ). When cultured in vitro, these blastocysts expanded, and those with an intact zona pellucida hatched. All embryos spread, similar to control blastocysts collected at d3.5 ( Figure 2 ). To determine if DFMO treatment in vitro could cause embryo arrest, embryos were either flushed at the morula stage at d2.5 and cultured for 24 h to blastocyst or blastocysts were flushed at d3.5. Blastocysts were then cultured with either 10 mM DFMO or in KSOM alone for a total of 5 days. However, there was no effect of DFMO treatment on embryo development, as all DFMO in vitro treated embryos were able to expand, hatch, and undergo trophoblast spreading, similar to controls ( Figure 2B) . For both the DFMO in vivo and DFMO in vitro blastocysts, there was no significant difference in the percentage of cultured blastocysts that spread compared to the control blastocysts (p> 0.05).
Histological examination of the uterus revealed an intact luminal epithelium in the treated, nonimplanted uteri (where blastocysts were flushed, subsequently referred to as DFMO blastocyst uteri), indistinguishable to that seen in control uteri at d3.5 ( Figure 1A , first column). In the uteri with partial implantation sites (IS, subsequently referred to as DFMO IS uteri), some animals had an embryo present with evidence of both a primary and secondary decidual zones ( Figure 1A , fourth column) that appeared not to differ from the implantation sites at d7.5 in control animals ( Figure 1A , fifth column). The remaining animals had evidence of incomplete luminal closure with the presence of a primary decidual zone but no secondary decidual zone.
Characterization of the polyamine pathway genes in control uteri indicated that the majority significantly increased their expression in the control uteri from d3.5 to d7.5. Arg1, Srm, Oaz1, and Azin 2 were the only genes that remained the same at all stages examined (Figure 3 ). In contrast, the expression of Smox and Paox, two of the three polyamine back-conversion enzymes, significantly decreased from d3.5 to d7.5. During diapause, a number of genes had decreased expression relative to the control d3.5 uteri including the polyamine synthesis enzymes Odc1, Srm, Sms, Smox, and two of the three enzymes that control ODC1 expression Oaz1 and Azin 1 (Figure 3) .
Examination of the polyamine pathway in the DFMO-treated uteri indicated a number of differences between the DFMO blastocyst uteri and the DFMO IS uteri (Figure 3 ). The majority of the genes in the DFMO blastocyst uteri had similar expression to The genes which differed had a significantly increased expression relative to diapause and included Amd1, the SAM conversion enzyme, Paox, one of the polyamine back-conversion enzymes, and all three of the enzymes that control ODC1 expression, Oaz1, Azin 1, and Azin 2. Azin 2 was also the only gene where expression in the DFMO blastocyst uteri was significantly higher than at any other stages. In addition, despite having decreased expression during diapause, the levels of Paox and Azin 1 were increased in the DFMO blastocyst uteri to levels similar to or above their expression at d3.5. For most of the polyamine pathway genes, there was no significant difference in expression between the DFMO IS uteri and the DFMO blastocyst uteri (Figure 3) . However, the expression of Odc1, Arg1, and Sat1 was significantly increased relative to diapause, only in the DFMO IS uteri and not in the DFMO blastocyst uteri. Furthermore, except for Paox, Arg1, and Azin2, the expression of all genes in the DFMO-treated uteri was significantly decreased relative to d7.5. In particular, expression of the SAM conversion enzyme Amd1 was significantly decreased in the DFMO blastocyst uteri relative to d7.5 and was further reduced in the DFMO IS uteri (Figure 3) .
Protein expression for ODC1 and AMD1, as revealed by immunofluorescence, showed similar trends to the mRNA expression profiles (Figure 4 ). Expression at d3.5 and during diapause was low for both ODC1 and AMD1. There was faint ODC1 expression in the luminal epithelium during diapause. At d5.5 and d7.5, AMD1 had distinct cytoplasmic expression at implantation sites. ODC1 was also present in the implantation sites but to a lesser extent compared to AMD1. For AMD1 and ODC1, the expression in both the DFMO blastocyst uteri and the DFMO IS uteri resembled the diapause uteri with low expression and no cytoplasmic expression observed for AMD1.
To further examine the effects of ODC1 inhibition on the uterus, the abundance of transcripts for a number of well-characterized implantation pathway genes was also examined (progesterone receptor, Pgr; estrogen receptor 1 (alpha) Esr1; homeobox A10, Hoxa10; bone morphogenetic protein 2, Bmp2; wingless-type MMTV integration site family, member 4, Wnt4; leukemia inhibitory factor, Lif; prostaglandin-endoperoxidase synthase 2, Ptgs2; and Msx1, Figure 5) . Expression of Pgr in the DFMO blastocyst uteri was not significantly different from any of the controls, including during diapause, but it was significantly decreased in the DFMO IS uteri compared to a d7.5 implantation site. Esr1 expression in both the DFMO blastocyst and DFMO IS uteri was significantly increased compared to both d3.5 and diapause to levels similar to the d7.5 uteri. For Hoxa10, Bmp2, and Msx1, the expression in both DFMO-treated uteri was similar to diapause. In contrast, there was a significant increase in Wnt4 expression in the DFMO IS uteri compared to during diapause, but this was still significantly decreased compared to both the d5.5 and d7.5 uteri. Lif and Ptgs2 expression remained the same at all stages examined.
Protein expression for MSX1 and the proliferation marker MKI67 confirmed the diapause state of the control uteri with reduced expression of MKI67 and continued expression of MSX1 ( Figure 6 ). Compared to during diapause, there was a similar expression of both MSX1 and MKI67 in the DFMO blastocyst uteri. However, in the DFMO IS uteri, MKI67 expression was increased to levels similar to the d3.5 control but with increased expression in the luminal epithelium, which was not seen at d3.5 ( Figure 6 ). 
Discussion
Reactivation from diapause is a highly complex event requiring activation of multiple pathways and processes with overlapping expression of numerous genes and proteins [11] , many of which are expected to also be involved in the implantation process. Here we have shown that polyamines, whilst essential for implantation in the mouse, also have an important role in controlling diapause, as we have previously shown in carnivore species [12, 19, 22] . In keeping with previous studies of the polyamine pathway expression during pregnancy in the mouse, the majority of the polyamine pathway genes had significantly increased expression in the control uteri from d3.5 to d7.5 [29, 31] . The spermine to spermidine back-conversion enzyme, Smox, was the only gene whose ex- pression was lowest at implantation, consistent with previous results, indicating the importance of spermine at this moment in gestation [29] . Previous studies reported detrimental effects of in vivo DFMO treatment on implantation during both normal pregnancy and diapause, with implantation prevented by about 75% [31] . However, implantation was only assessed at either d4.5 or d17.5 and the fate of the nonimplanted embryos was not reported [29] [30] [31] . We hypothesized, correctly, that inhibition of ODC1 with DFMO could cause the blastocyst to enter into an embryonic diapause-like state.
Characterization of the polyamine pathway during diapause in this study revealed a number of genes with decreased expression relative to the d3.5 uteri including the polyamine synthesis enzymes Odc1, Srm, Sms, and Smox, similar to that found for Odc1 previously [31] . The overall expected effect is a decrease in levels of all three polyamines. Azin 1 was also decreased, which is expected to further increase the amount of ODC1 degraded but since levels of Azin 2 stayed the same and the degradation enzyme Oaz1 was also decreased, it is difficult to say how relevant this result is to the abundance of polyamines. This caveat notwithstanding, we believe it justified to conclude that a decrease in polyamine levels causes the blastocyst to enter into diapause. This concurs with previous studies in obligate carnivore diapause, indicating that this signaling modality is evolutionarily conserved [1, 22] .
In this study, treatment with DFMO maintained embryos in the blastocyst stage over a period of 5 days, similar to that observed for embryonic diapause. Identification of an embryo in diapause is not well characterized in any species beyond the canonical cell cycle arrest and decreased metabolism. Although a number of factors have been identified in the diapause embryo, there is currently no definitive classification or marker characterizing this condition in any species [1, 35, 36] . In this study, the maintenance of blastocysts with reduced proliferation for an extended period of time in vivo indicated that these blastocysts had entered into diapause. Furthermore, the ability of the blastocysts flushed from the DFMO-treated uteri to expand, hatch, and spread in vitro, in a manner indistinguishable from those recovered from saline-treated controls, indicated that there was no detrimental effect of DFMO treatment on the blastocyst. These results provide further evidence that the treatment induced and maintained the embryo in diapause. However, confirmation of embryo viability requires transfer of these embryos into pseudopregnant mothers to establish that implantation and pregnancy were not affected, since DFMO inhibition of ODC1 is irreversible and preliminary experiments indicated that recovery in vivo post-DFMO treatment was impaired (data not shown). It may be that additional factors are required to induce implantation in vivo. Reactivation from experimentally induced diapause in the mouse requires estradiol [2, 8] and although previous treatment of diapause embryos with DFMO concurrently with estradiol failed to result in implantation [31] , the addition of polyamines may induce reactivation and subsequent implantation in vivo.
Previous studies have reported that diapause blastocysts cultured in vitro do not undergo trophoblast outgrowth when cultured with 10 mM DFMO [37] . However, we were unable to induce diapause in d3.5 blastocysts after treating with 10 mM DFMO. The blastocyst appears to have its own supply of polyamines, as ODC1 is present in the embryo from the zygote to the blastocyst stage, and studies have shown that some maternal expression of ODC1 persists to the blastocyst stage [23, 24] . Thus, there may have been sufficient levels of polyamines present in the blastocyst to maintain development in vitro, which were then exhausted during diapause in the above study. In this study, culture from the morula stage to blastocyst prior to DFMO treatment was also unable to prevent trophoblast outgrowth. It may be possible to exhaust endogenous levels of polyamines by culture of embryos from the one cell to blastocyst prior to DFMO treatment. In porcine embryos cultured from the two-cell stage, DFMO inhibition reduces both cell number and total number of embryos that develop to blastocyst [38] . Alternatively, it is possible that there may have been compensatory effects of DFMO treatment and coculture with DFMO, and an AMD1 inhibitor may be required since previous studies have shown an increased effect of dual inhibition on embryo development [27, 32] .
In contrast, characterization of a uterus in diapause can be determined by comparing it to both a d3.5 uterus and the extent to which the uterus undergoes the decidualization process. In this study, examination of a number of well-characterized implantationrelated genes indicated that the majority had similar expression in the DFMO blastocyst uteri to either a diapause or d3.5 stage uteri, indicating a failure to initiate implantation. Previous studies have shown that although DFMO can affect the formation of the corpus luteum and hence progesterone secretion, there was no effect of DFMO treatment on progesterone levels during the preimplantation period [22, 39] and similarly in this study, there was no significant effect of DFMO treatment on the expression of Pgr in the DFMO blastocyst uteri. In contrast, the expression of Esr1 in the DFMO blastocyst uteri was significantly increased compared to both d3.5 and diapause, suggesting that the uterus may have been more responsive to estrogen and this could cause it to enter into a refractory state [40] . This was supported by the continued expression of MSX1 and reduced proliferation of the stroma and glandular epithelium in the DFMO blastocyst uteri, similar to diapause. However, both Lif and Ptgs2 were still expressed, indicating a failure of complete uterine quiescence [11] . Despite continual Ptgs2 expression across all stages examined, there was significantly reduced expression of Bmp2 and Wnt4 in the DFMO blastocyst uteri compared to both d5.5 and d7.5 uteri, and Ptgs2, essential for implantation, is a target of both genes [41, 42] .
There are two competing hypotheses about how uterine signaling controls entry into diapause: either the blastocyst lacks a factor necessary for its continued development or the arrest is actively maintained by inhibition of blastocyst development [1] . In this study, the ability of the blastocysts to reactivate in vitro their lack of in vivo reactivation and the inability of DFMO, to maintain their arrest in vitro suggest that the DFMO treatment was acting predominantly on the uterus and that polyamines are a limiting factor for continued blastocyst development. This is in agreement with previous work that concluded that the effect of DFMO was predominantly on the uterus rather than the embryo [31] .
In general, the expression of the polyamine pathway genes in the DFMO uteri with blastocysts resembled the expression in a diapause uterus, but with two main differences ( Figure 7) . One effect was an increase in AMD1 expression to a level resembling a d5.5 uterus. This increase in AMD1, combined with the increase in Paox expression, is expected to increase the levels of spermidine as well as maximize the available levels of all three polyamines. In the mink, DFMO treatment of pregnant females significantly reduced concentrations of putrescine and spermidine in the uterus [22] ; thus, this may be a compensatory mechanism. The other noticeable difference between the diapause and the DFMO-treated uteri was the increases in both Azin 1 and Azin 2, which is expected to contribute toward maximizing the quantity of polyamines available. AZINs can bind to OAZ with a higher affinity than ODC1, thus preventing ODC1 degradation, and they can stimulate polyamine uptake [13, 17] . In ewes, knockdown of ODC1 results in conceptuses that are still viable due to the presence of an alternative pathway which converts arginine to putrescine via arginine decarboxylase and agmatinase in the absence of ODC1 [43] . However, in this study, no expression of agmatinase could be detected in the uterus (data not shown), suggesting that this pathway was not active in the mouse uterus.
Unexpectedly, the only difference between the DFMO IS uteri and the DFMO blastocyst uteri for the implantation factors examined appeared to be the significant decrease in expres- sion of Pgr and a significant increase in expression of Wnt4. Progesterone inhibits estrogen-induced epithelium proliferation and stimulates stromal proliferation [11] ; thus, the continued proliferation of the luminal epithelium and the lack of expression of Bmp2, a progesterone responsive gene, would appear due to this decrease. In contrast, WNT4 is required for stromal cell decidualization [42] ; thus, the increase in its expression in the DFMO IS uteri, together with the maintenance of Ptgs2 expression, indicates that part of the implantation process had begun. However, this appeared incomplete since although WNT4 can act independently of BMP2, it is also a target of BMP2-induced decidualization and both Bmp2 and Hoxa10 were significantly decreased relative to both d5.5 and d7.5 uteri. BMP2 and HOXA10 are early markers of decidualization, which are expressed after attachment of the embryo, indicating that this failure occurred early in the implantation process [44] . Consistent with this, both MSX1 and Lif expression were maintained, which together with the continued proliferation of the luminal epithelium indicated a dysregulation at the initiation of the implantation process. Furthermore, there was increased Odc1, Smox, Arg1, and Sat1 expression in the DFMO IS uteri compared to diapause that was not observed in the DFMO blastocyst uteri. An increase in Sat1 (the enzyme required for back conversion of spermine and spermidine) along with the increase in Smox (the enzyme specifically required for back conversion of spermine) suggests that the levels of spermine were decreased in the DFMO IS uteri. Interestingly, levels of Amd1 were reduced in the DFMO IS uteri compared to the DFMO blastocyst uteri and may have also contributed to a decrease in spermine levels. Together these results suggest that although the decidualization process had begun in the DFMO IS uteri, it was incomplete and required additional signaling, presumably from polyamines, to progress.
Conclusion
We conclude that in vivo ODC1 inhibition induces a diapause-like state in mouse embryos. Characterization of the uterus after DFMO treatment indicated entry of the uterus into quiescence causing the blastocysts to arrest. In those embryos that were able to implant, DFMO treatment caused a failure in the decidualization process. As we have shown in carnivores, these results suggest that embryonic diapause is caused by the paucity of polyamines necessary for activation of the embryo. Recognizing when the uterus is receptive to an embryo is important in both identifying the etiology of failed pregnancy and in ensuring successful embryo transfer after assisted reproduction procedures.
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